Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 435, 104-108 (5 May 2005) | doi:10.1038/nature03505; Received 7 February 2005; Accepted 28 February 2005
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing
Xiaoqin Ye1,7, Kotaro Hama2,7, James J. A. Contos4, Brigitte Anliker1, Asuka Inoue2, Michael K. Skinner5, Hiroshi Suzuki3,6, Tomokazu Amano3, Grace Kennedy1, Hiroyuki Arai2, Junken Aoki2 & Jerold Chun1
- Department of Molecular Biology, Helen L. Dorris Child and Adolescent Neuropsychiatric Disorder Institute, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA
- Graduate School of Pharmaceutical Sciences, and
- Department of Developmental Medical Technology (Sankyo), Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
- Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109-1024, USA
- Center for Reproductive Biology, School of Molecular Bioscience, Washington State University, Pullman, Washington 99164-4231, USA
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan
- *These authors contributed equally to this work
Correspondence to: Jerold Chun1 Correspondence and requests for materials should be addressed to J.C. (Email: jchun@scripps.edu).
Abstract
Every successful pregnancy requires proper embryo implantation. Low implantation rate is a major problem during infertility treatments using assisted reproductive technologies1. Here we report a newly discovered molecular influence on implantation through the lysophosphatidic acid (LPA) receptor LPA3 (refs 2–4). Targeted deletion of LPA3 in mice resulted in significantly reduced litter size, which could be attributed to delayed implantation and altered embryo spacing. These two events led to delayed embryonic development, hypertrophic placentas shared by multiple embryos and embryonic death. An enzyme demonstrated to influence implantation, cyclooxygenase 2 (COX2) (ref. 5), was downregulated in LPA3-deficient uteri during pre-implantation. Downregulation of COX2 led to reduced levels of prostaglandins E2 and I2 (PGE2 and PGI2), which are critical for implantation1. Exogenous administration of PGE2 or carbaprostacyclin (a stable analogue of PGI2) into LPA3-deficient female mice rescued delayed implantation but did not rescue defects in embryo spacing. These data identify LPA3 receptor-mediated signalling as having an influence on implantation, and further indicate linkage between LPA signalling and prostaglandin biosynthesis.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Reproductive biology Fatty link to fertilityNature News and Views (05 May 2005)
Embryology: Very Early MammalsNature News and Views (06 Jun 1970)
See all 3 matches for News And ViewsRESEARCH
LPA 3 -mediated lysophosphatidic acid signalling in embryo implantation and spacingNature Letters to Editor (05 May 2005)
Aberrant cannabinoid signaling impairs oviductal transport of embryosNature Medicine Article (01 Oct 2004)
See all 46 matches for Research